MA50149B1 - Procedé pour la préparation de l'anneau de pipérazine pour la synthèse de pyrazinocarbazole - Google Patents
Procedé pour la préparation de l'anneau de pipérazine pour la synthèse de pyrazinocarbazoleInfo
- Publication number
- MA50149B1 MA50149B1 MA50149A MA50149A MA50149B1 MA 50149 B1 MA50149 B1 MA 50149B1 MA 50149 A MA50149 A MA 50149A MA 50149 A MA50149 A MA 50149A MA 50149 B1 MA50149 B1 MA 50149B1
- Authority
- MA
- Morocco
- Prior art keywords
- synthesis
- preparation
- piperazine ring
- pyrazinocarbazole
- pirlindole
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
La présente invention concerne un procédé amélioré pour la synthèse d'un cycle pipérazine, en particulier pour la préparation de composés hétérocycliques utiles en tant qu'intermédiaires dans la synthèse de pyrazinocarbazoles tels que le pirlindole antidépresseur. Le procédé de l'invention est utile pour préparer des énantiomères de pirlindole, ou un sel pharmaceutiquement acceptable de ceux-ci.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PT11003717 | 2017-04-21 | ||
EP17167851.9A EP3392250A1 (fr) | 2017-04-21 | 2017-04-24 | Procedé pour la préparation de l'anneau de pipérazine pour la synthèse de pyrazinocarbazole |
PCT/IB2018/052753 WO2018193414A1 (fr) | 2017-04-21 | 2018-04-20 | Procédé de préparation d'un cycle pipérazine pour la synthèse de dérivés de pyrazinocarbazole |
Publications (2)
Publication Number | Publication Date |
---|---|
MA50149A MA50149A (fr) | 2021-05-26 |
MA50149B1 true MA50149B1 (fr) | 2022-03-31 |
Family
ID=58632260
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA50149A MA50149B1 (fr) | 2017-04-21 | 2018-04-20 | Procedé pour la préparation de l'anneau de pipérazine pour la synthèse de pyrazinocarbazole |
Country Status (21)
Country | Link |
---|---|
US (1) | US11008327B2 (fr) |
EP (2) | EP3392250A1 (fr) |
JP (1) | JP7121750B2 (fr) |
KR (1) | KR102525824B1 (fr) |
CN (1) | CN110831943B (fr) |
AU (1) | AU2018254238B2 (fr) |
BR (1) | BR112019022073A2 (fr) |
CA (1) | CA3060592A1 (fr) |
CL (1) | CL2019002967A1 (fr) |
CO (1) | CO2019012592A2 (fr) |
CY (1) | CY1125139T1 (fr) |
EA (1) | EA038552B1 (fr) |
EC (1) | ECSP19076875A (fr) |
IL (1) | IL270048B (fr) |
MA (1) | MA50149B1 (fr) |
PE (1) | PE20191739A1 (fr) |
PT (1) | PT3612534T (fr) |
SA (1) | SA519410309B1 (fr) |
UA (1) | UA123692C2 (fr) |
WO (1) | WO2018193414A1 (fr) |
ZA (1) | ZA201907517B (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111620882B (zh) * | 2020-06-12 | 2021-08-31 | 欧洛德(武汉)光电科技有限公司 | 新型用于有机电致发光器件的化合物及应用 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3288859A (en) | 1965-03-30 | 1966-11-29 | Procter & Gamble | Reactions of alkali metal salts of sulfinyl carbanions and alkanesulfenates with epoxy compounds and novel compounds derived therefrom |
IT1312539B1 (it) * | 1999-04-16 | 2002-04-22 | Erregierre Spa | Processo per la preparazione del pirlindolo cloridrato. |
TN2016000498A1 (en) | 2014-05-09 | 2018-04-04 | Tecnimede Sociedade Tecnico Medicinal S | (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine. |
WO2015171003A1 (fr) | 2014-05-09 | 2015-11-12 | Tecnimede Sociedade Tecnico-Medicinal S.A. | Procédé d'obtention d'énantiomères de pirlindole optiquement actifs et de sels de ceux-ci |
AU2014393487B2 (en) * | 2014-05-09 | 2020-01-02 | Tecnimede Sociedade Tecnico-Medicinal S.A. | Pharmaceutically acceptable salts of pirlindole enantiomers for use in medicine |
CN104774208A (zh) * | 2015-04-24 | 2015-07-15 | 南京靖龙药物研发有限公司 | 一种氘标记吡吲哚盐酸盐的制备方法 |
-
2017
- 2017-04-24 EP EP17167851.9A patent/EP3392250A1/fr not_active Withdrawn
-
2018
- 2018-04-20 EP EP18725642.5A patent/EP3612534B1/fr active Active
- 2018-04-20 CN CN201880028465.4A patent/CN110831943B/zh active Active
- 2018-04-20 WO PCT/IB2018/052753 patent/WO2018193414A1/fr active Application Filing
- 2018-04-20 BR BR112019022073-9A patent/BR112019022073A2/pt active Search and Examination
- 2018-04-20 AU AU2018254238A patent/AU2018254238B2/en active Active
- 2018-04-20 EA EA201992384A patent/EA038552B1/ru unknown
- 2018-04-20 JP JP2019557487A patent/JP7121750B2/ja active Active
- 2018-04-20 KR KR1020197033652A patent/KR102525824B1/ko active IP Right Grant
- 2018-04-20 CA CA3060592A patent/CA3060592A1/fr active Pending
- 2018-04-20 MA MA50149A patent/MA50149B1/fr unknown
- 2018-04-20 US US16/607,046 patent/US11008327B2/en active Active
- 2018-04-20 PT PT187256425T patent/PT3612534T/pt unknown
- 2018-04-20 PE PE2019002065A patent/PE20191739A1/es unknown
- 2018-04-20 UA UAA201910930A patent/UA123692C2/uk unknown
- 2018-04-20 IL IL270048A patent/IL270048B/en unknown
-
2019
- 2019-10-16 SA SA519410309A patent/SA519410309B1/ar unknown
- 2019-10-17 CL CL2019002967A patent/CL2019002967A1/es unknown
- 2019-10-30 EC ECSENADI201976875A patent/ECSP19076875A/es unknown
- 2019-11-12 CO CONC2019/0012592A patent/CO2019012592A2/es unknown
- 2019-11-13 ZA ZA201907517A patent/ZA201907517B/en unknown
-
2022
- 2022-03-04 CY CY20221100187T patent/CY1125139T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP3612534A1 (fr) | 2020-02-26 |
CN110831943B (zh) | 2022-05-03 |
IL270048B (en) | 2022-06-01 |
MA50149A (fr) | 2021-05-26 |
CY1125139T1 (el) | 2023-06-09 |
EP3392250A1 (fr) | 2018-10-24 |
PT3612534T (pt) | 2022-03-22 |
KR20200006544A (ko) | 2020-01-20 |
CN110831943A (zh) | 2020-02-21 |
CA3060592A1 (fr) | 2018-10-25 |
US20200131186A1 (en) | 2020-04-30 |
ZA201907517B (en) | 2020-11-25 |
JP7121750B2 (ja) | 2022-08-18 |
AU2018254238B2 (en) | 2022-02-24 |
CL2019002967A1 (es) | 2020-04-13 |
EA201992384A1 (ru) | 2020-02-19 |
US11008327B2 (en) | 2021-05-18 |
BR112019022073A2 (pt) | 2020-08-18 |
EP3612534B1 (fr) | 2021-12-22 |
PE20191739A1 (es) | 2019-12-12 |
EA038552B1 (ru) | 2021-09-14 |
ECSP19076875A (es) | 2020-02-28 |
UA123692C2 (uk) | 2021-05-12 |
CO2019012592A2 (es) | 2020-01-17 |
JP2020517664A (ja) | 2020-06-18 |
KR102525824B1 (ko) | 2023-04-25 |
WO2018193414A1 (fr) | 2018-10-25 |
AU2018254238A1 (en) | 2019-10-31 |
SA519410309B1 (ar) | 2021-11-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA48798B1 (fr) | Procédé de production d'ozanimod | |
MA41607A (fr) | Sels d'un inhibiteur de pi3k et procédés de préparation de ces sels | |
FR3087439B1 (fr) | Procédé pour la préparation de 3α-hydroxy-5α-prégnan-20-one (brexanolone) | |
MA40895A (fr) | Synthèse de copanlisib et son sel de dichlorhydrate | |
TN2018000319A1 (en) | Macrocyclic mcl1 inhibitors for treating cancer | |
MA42341B2 (fr) | Inhibiteur de protéine kinase, son procédé de préparation et son utilisation médicale | |
MA47970B1 (fr) | Composé inhibiteur de jak à base d'imidazo-pipéridine fusionnée | |
NZ765535A (en) | Enantiomeric separation of racemic nicotine by addition of an o,o’-disubstituted tartaric acid enantiomer | |
MA35351B1 (fr) | Nouveau dérivé 1,2,3,4- tétrahydroquinoléine utile pour le traitement du diabète. | |
MA52948B1 (fr) | Composés | |
PE20221420A1 (es) | Procedimiento fotoquimico para la preparacion de (4r,4s)-4-(4-ciano-2-metoxifenil)-5-etoxi-2,8-dimetil-1,4-dihidro-1,6-naftiridin-3-carboxamida | |
MA37866B1 (fr) | Dérivés de type aza-indazole ou diaza-indazole pour le traitement de la douleur | |
MA40480B1 (fr) | Procédé de cristallisation de dérivés d'aripiprazole dans des formulations à libération prolongée pour le traitement de la schizophrénie | |
PH12016501100B1 (en) | Ethynyl-imidazolin-2,4-dione derivatives as mglur4 modulators | |
MA50149B1 (fr) | Procedé pour la préparation de l'anneau de pipérazine pour la synthèse de pyrazinocarbazole | |
FR3062851B1 (fr) | Procede de preparation monotope de composes organo-iodes | |
NZ767900A (en) | Pyrazo-tetrahydroisoquinoline derivatives as dopamine d1 receptor positive modulators | |
MA45665B1 (fr) | Dérivés d'éthynyle | |
BR112022007102A2 (pt) | Métodos para a preparação de ácido 5-bromo-2-(3-cloro-piridin-2-il)-2h-pirazol-3-carboxílico | |
EA202190832A1 (ru) | Способы получения соединений пиразола | |
EA202190330A1 (ru) | Способ получения полиморфной формы робенакоксиба | |
MA41975B1 (fr) | Derives d'aminohydrothiazine fusionnee contenant du tetrahydrofurane utiles dans le traitement de la maladie d'alzheimer | |
CO2022015361A2 (es) | Nuevos derivados de imidazolona como inhibidores de proteínas cinasas en particular cinasa 1a regulada por fosforilación de la tirosina de especificidad dual (dyrk1a), cinasa 1 similar a las citolisinas dependientes del colesterol (clk1) y/o cinasa 4 similar a las citolisinas dependientes del colesterol (clk4) | |
CO2022001513A2 (es) | Proceso e intermediarios para la preparación de piroxasulfona | |
MX2022002568A (es) | Proceso para preparar (r)-4-aminoindano y amidas correspondientes. |